Published in Hepatitis Weekly, July 24th, 1995
The method, based on multiple HCV core peptides, should be of interest for clinicians in cases of clinical hepatitis with detectable HCV RNA in serum and in which the clinical background is unknown, stated Zhu-Xu Zhang and colleagues, Huddinge University Hospital, Huddinge, Sweden ("Distinguishing Acute from Symptomatic Chronic Hepatitis C Virus (HCV) Infection by Site-Directed Serology of the HCV Structural Proteins," the Journal of Infectious Diseases, May 1995;171:1356-1359).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.